Whole-genomic survey of oligodendroglial tumors: Correlation between allelic imbalances and gene expression profiles

Journal of Neuro-Oncology

Volumn 103, Issue 1, 2011, Pages 71-85

  Ferrer Luna, Rubén ^a   Núñez, Lina ^b   Piquer, José ^c   Arias, Eugenia ^b   Dasí, Francisco ^d   Cervio, Andrés ^b   Arakaki, Naomi ^b   Sevlever, Gustavo ^b   Celda, Bernardo ^a,e   Martinetto, Horacio ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b FLENI   (Argentina)

^c HOSPITAL DE LA RIBERA   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Allelic imbalances; Gene expression; Loss of heterozygosity; Oligodendroglial tumors

Indexed keywords

ARF PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTATHIONE TRANSFERASE P1; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 1; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P53; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELIC IMBALANCE; ARF GENE; ARTICLE; CHILD; CHROMOSOME 10; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 17P; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 4; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; CYCLIN DEPENDENT KINASE INHIBITOR 2A GENE; DNA METHYLATION; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; EPIGENETICS; GENE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENETIC CORRELATION; GENETIC GAIN; GENOMICS; GLUTATHIONE TRANSFERASE P1 GENE; HAPLOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; ISOCITRATE DEHYDROGENASE 1 GENE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE GENE; MICROSATELLITE MARKER; MONOSOMY; OLIGODENDROGLIOMA; PHENOTYPE; PRESCHOOL CHILD; PROGNOSIS; PROMOTER REGION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; TRISOMY; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; ALLELIC IMBALANCE; BLOTTING, WESTERN; BRAIN NEOPLASMS; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN; DNA METHYLATION; EPIGENOMICS; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MUTATION; OLIGODENDROGLIOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 79959938168     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0369-4     Document Type: Article

References (49)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 114:97-109 (Pubitemid 47103521)
2. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN (2003) Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63:1602-1607 (Pubitemid 36373650)
3. French PJ, Swagemakers SMA, Nagel JHA, Kouwenhoven MCM, Brouwer E, van der Spek P, Luider TM, Kros JM, van den Bent MJ, Smitt PAS (2005) Gene expression profiles associated with treatment response in Oligodendrogliomas. Cancer Res 65:11335-11344 (Pubitemid 41821690)
4. Ferrer-Luna R, Mata M, Nunez L, Calvar J, Dasi F, Arias E, Piquer J, Cerda-Nicolas M, Taratuto AL, Sevlever G, Celda B, Martinetto H (2009) Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression. J Neurooncol 95:343-354
5. Griffin CA, Burger P, Morsberger L, Yonescu R, Swierczynski S, Weingart JD, Murphy KM (2006) Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss. J Neuropathol Exp Neurol 65:988-994 (Pubitemid 44521799)
6. Bigner SH, Matthews MR, Rasheed BK, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD (1999) Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 155:375-386 (Pubitemid 29370388)
7. Jeuken JWM, Sprenger SHE, Wesseling P, Macville MVE, von Deimling A, Teepen H, van Overbeeke JJ, Boerman RH (1999) Identification of subgroups of high-grade oligodendroglial tumors by comparative genomic hybridization. J Neuropathol Exp Neurol 58:606-612 (Pubitemid 29264940)
8. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175-1190 (Pubitemid 24345665)
9. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636-645 (Pubitemid 30078545)
10. Watanabe T, Nakamura M, Kros JM, Burkhard C, Yonekawa Y, Kleihues P, Ohgaki H (2002) Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas. Acta Neuropathol 103:267-275 (Pubitemid 36075328)
11. Jeuken JW, Sprenger SH, Boerman RH, von Deimling A, Teepen HL, van Overbeeke JJ, Wesseling P (2001) Subtyping of oligoastrocytic tumors by comparative genomic hybridization. J Pathol 194:81-87
12. Maintz D, Fiedler K, Koopmann J, Rollbrocker B, Nechev S, Lenartz D, Stangl AP, Louis DN, Schramm J, Wiestler OD, von Deimling A (1997) Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 56:1098-1104 (Pubitemid 27430471)
13. Kros JM, van Run PR, Alers JC, Beverloo HB, van den Bent MJ, Avezaat CJ, van Dekken H (1999) Genetic aberrations in oligodendroglial tumors: an analysis using comparative genomic hybridization (CGH). J Pathol 188:282-288 (Pubitemid 29317772)
14. McDonald JM, Ju See S, Tremont IW, Colman H, Gilbert MR, Groves M, Burger PC, Louis DN, Giannini C, Fuller G, Passe S, Blair H, Jenkins RB, Yang H, Ledoux A, Aaron J, Tipnis U, Zhang W, Hess K, Aldape K (2005) The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors. Cancer 104:1468-1477 (Pubitemid 41356162)
15. Gadji M, Fortin D, Tsanaclis AM, Drouin R (2009) Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas? Cancer Genet Cytogenet 194:12-22
16. Giannini C, Burger PC, Berkey BA, Cairncross JG, Jenkins RB, Mehta M, Curran WJ, Aldape K (2008) Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402. Brain Pathol 18:360-369 (Pubitemid 351782844)
17. Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN (2001) Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 7:839-845 (Pubitemid 32708719)
18. Ohgaki H, Kleihues P (2009) Genetic alteration and signaling pathway in the evolution of gliomas. Cancer Sci 100:2235-2241
19. Yan H, Bigner DD, Velculescu V, Parsons DW (2009) Mutant metabolic enzymes are at the origin of gliomas. Cancer Res 69:9157-9159
20. Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C, Wong WH, Li C (2004) dChipSNP: significance curve and clustering of SNP array-based loss-of-heterozygosity data. Bioinformatics 20:1233-1240 (Pubitemid 38807579)
21. Li C, Wong WH (2001) Model based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98:31-36 (Pubitemid 32095858)
22. Li C, Wong WH (2001) Model based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol 2:8-14
23. Beroukhim R, Ling M, Park Y, Hao K, Zhao X, Garraway LA, Fox E, Hochberg EP, Mellinghoff IK, Hofer MD, Descaceaud A, Rubin MA, Meyerson M, Sellers WR, Li C (2006) Inferring LOH from unpaired tumour using high density oligonucleotide SNP arrays. PLoS Comput Biol 2:e41
24. Zhao X, Li C, Paez G, Chin K, Janne P, Chen TH, Girard L, Minna J, Christiani D, Leo C, Gray JW, Sellers WR (2004) An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 64:3060-3071 (Pubitemid 38581405)
25. Paulin R, Grigg GW, Davey MW, Pipper AA (1998) Urea improves efficiency of bisulphite-mediated sequencing of 50-methylcytosine in genomic DNA. Nucleic Acids Res 26:5009-5010 (Pubitemid 28491185)
26. Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, Cantor CR, Field JK, van den Boom D (2005) Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA 102:15785-15790 (Pubitemid 41552820)
27. Coolen MW, Statham AL, Gardiner-Garden M, Clark SJ (2007) Genomic profiling of CpG methylation and allelic specificity using quantitative high throughput mass spectroscopy: critical evaluation and improvements. Nucleic Acids Res 35:1-14
28. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60:5954-5958
29. Meyer J, Pusch S, Balss J, Capper D, Mueller W, Christians A, Hartmann C, von Deimling A (2009) PCR- and restriction endonuclease-based detection of IDH1 mutations. Brain Pathol 20:298-300
30. Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahasi H, Mukasa A, Asai A, Kirino T (2002) Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4 and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin Cancer Res 8:196-201 (Pubitemid 34101478)
31. Jeuken JMW, Von Deimling A, Wesseling P (2004) Molecular pathogenesis of oligodendroglial tumors. J Neurooncol 70:161-181 (Pubitemid 39545730)
32. TCGA (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068
33. Ricard D, Kaloshi G, Amiel-Benouaich A, Lejeune J, Marie Y, Mandonnet E, Kujas M, Mokhtari K, Taillibert S, Laigle-Donadey F, Carpentier AF, Omuro A, Capelle L, Duffau H, Cornu P, Guillevin R, Sanson M, Hoang-Xuan K, Delattre JY (2007) Dynamic history of low grade gliomas before and after temozolomide treatment. Ann Neurol 61:484-490 (Pubitemid 46878776)
34. Bromberg JE, Van den Bent MJ (2009) Oligodendrogliomas: molecular biology and treatment. Oncologist 14:155-163
35. Mukasa A, Ueki K, Matsumoto S, Tsutsumi S, Nishikawa R, Fujimaki T, Asai A, Kirino T, Aburatani H (2002) Distinction in gene expression profile of oligodendrogliomas with and without allelic loss of 1p. Oncogene 21:3961-3968 (Pubitemid 34679237)
36. Ducray F, Idbaih A, Reyniès A, Bièche I, Thillet J, Mokhtari K, Lair S, Marie Y, Paris S, Vidaud M, Hoang-Xuan K, Delattre O, Delattre JY, Sanson M (2008) Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. Mol Cancer 7:1-17
37. Benetkiewicz M, Idbaih A, Cousin P, Boisselier B, Marie Y, Criniere E, Hoang-Xuan K, Delattre JY, Sanson M, Delattre O (2009) NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas. PLoS ONE 4:e4107
38. Zlatescu MC, Yazdi A, Sasaki H, Megyesi J, Betensky RA, Louis DN, Cairncross JG (2001) Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 61:6713-6715 (Pubitemid 32896492)
39. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, Du J, Kau T, Thomas RK, Shah K, Soto H, Perner S, Prensner J, Debiasi RM, Demichelis F, Hatton C, Rubin MA, Garraway LA, Nelson SF, Liau L, Mischel PS, Cloughesy TF, Meyerson M, Golub TA, Lander ES, Mellinghoff IK, Sellers WR (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci USA 104:20007-20012
40. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343:1350-1354
41. Dong SM, Pang JC, Poon WS, Hu J, To KF, Chang AR, Ng HK (2001) Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. J Neuropathol Exp Neurol 60:808-816 (Pubitemid 32678261)
42. Möllemann M, Wolter M, Felsberg J, Collins VP, Reifenberger G (2005) Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. Int J Cancer 113:379-385 (Pubitemid 40038704)
43. Brandes AA, Tosoni A, Cavallo G, Reni M, Franceschi E, Bonaldi L, Bertorelle R, Gardiman M, Ghimenton C, Iuzzolino P, Pession A, Blatt V, Herman M (2006) Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study. J Clin Oncol 24:4746-4753 (Pubitemid 46630938)
44. Nutt CL, Noble M, Chambers AF, Cairncross JG (2000) Differential expression of drug resistance genes and chemosensitivity in glial cells lineages correlate with differential response of oligodendrogliomas and astrocitomas to chemotherapy. Cancer Res 60:4812-4818
45. Dang L, White D, Gross S (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739-747
46. Bleeker F, Atai N, Lamba S, Jonker A, Rijkeboer D, Bosch K, Tigchelaar W, Troost D, Vandertop W, Bardelli A, Van Noorden C (2010) The prognostic IDH1R132 mutation is associated with reduced NAP?-dependent IDH activity in glioblastoma. Acta Neuropathol [Epub ahead of print]
47. Bredel M, Scholtens D, Harsh G, Bredel C, Chandler J, Renfrow J, Yadav A, Vogel H, Scheck A, Tibshirani R, Sikic B (2009) A network model of a cooperative genetic landscape in brain tumours. JAMA 302:261-275
48. Kotliarov Y, Steed M, Christopher N, Walling J, Su Q, Center A, Heiss J, Rosenblum M, Mikkelsen T, Zenklusen J, Fine H (2006) High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res 66:9428-9436 (Pubitemid 44623639)
49. Kotliarov Y, Kotliarova S, Charong N, Li A, Walling J, Aquilanti E, Ahn S, Steed M, Su Q, Center A, Zenklusen J, Fine H (2009) Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes. Cancer Res 69:596-603